Related Experiment Videos
Recent advances in understanding the molecular mechanisms of tamoxifen action
1Department of Biological Chemistry, Hebrew University of Jerusalem, Israel.
Cancer Investigation
|July 29, 1998
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The antitumor agent tamoxifen inhibits breakdown of polyphosphoinositides in GH4C1 cells.
The Journal of pharmacology and experimental therapeutics·1994
Tamoxifen and vanadate synergize in causing accumulation of polyphosphoinositides in GH4C1 membranes.
The Journal of pharmacology and experimental therapeutics·1993
Desensitization of substance P-induced K+ release in rat parotid.
European journal of pharmacology·1985
Neurokinin B is a preferred agonist for a neuronal substance P receptor and its action is antagonized by enkephalin.
Proceedings of the National Academy of Sciences of the United States of America·1985
Substance P degrading systems of rat parotid and hypothalamus.
Biochimica et biophysica acta·1984
beta-Adrenergic receptors stimulated peroxidase secretion from rat lacrimal gland.
Biochimica et biophysica acta·1981
Tat-dependent protein translocation and its evolution.
FEMS microbiology reviews·2026
Theranostics in the management of prostate cancer: from concept to clinical practice.
Expert review of clinical pharmacology·2026
miR-324-5p acts as an independent prognostic biomarker and inhibits pediatric medulloblastoma progression by targeting HOXA9.
Nucleosides, nucleotides & nucleic acids·2026
Th1-biased iNKT cell agonist-loaded liposomal peptide vaccines synergize with a PD-L1 inhibitor to boost immunotherapy against gastric cancer.
Chemical communications (Cambridge, England)·2026
Nanoparticle-Based Delivery Strategies for Targeted Protein Degradation.
Advanced healthcare materials·2026